Prof. El Aidy wins Gut Microbiome Therapeutic Innovation challenge
Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute ( GBB ) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation ( GMTI ) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Last modified: | 23 May 2025 08.43 a.m. |
More news
-
16 September 2025
The ocean absorbs carbon from the air, but what if the temperature increases?
‘Fortunately, seawater absorbs carbon dioxide (CO₂). If it didn’t, things would have been over and done with already,’ according to climate and ocean researchers Richard Bintanja and Rob Middag. But what actually happens to the ocean's carbon...
-
10 September 2025
Funding for Feringa and Minnaard from National Growth Fund project Big Chemistry
Two UG research projects have received funding from the National Growth Fund project Big Chemistry via NWO.
-
09 September 2025
Carbon dioxide’s fingerprint
In the year 2000, Harro Meijer, Professor of Isotope Physics at the University of Groningen, set up the Lutjewad Measurement Station near Hornhuizen. There, researchers from Groningen are mapping where CO2 in the atmosphere originates and where it...